Basics of Biosimilars


9:30 a.m. – 9:40 a.m.    Welcome and Introductions

  • Sarah Dash, MPH, president and chief executive officer, Alliance for Health Policy, @AllHealthPolicy
  • Scott White, MBA, company group chairman, North America Pharmaceuticals, Johnson & Johnson, @JanssenUS

9:40 a.m. – 10:20 a.m.  Panelist Opening Remarks

  • Sameer V. Awsare, M.D., FACP, associate executive director, The Permanente Medical Group
  • Jeremy Sharpsenior vice president, Waxman Strategies
  • Adam J. Fein, Ph.D., chief executive officer, Drug Channels Institute, @DrugChannels
  • Anna Hyde, M.A., vice president, Advocacy and Access, Arthritis Foundation, @AnnaHydeAF


10:20 a.m. – 11:00 a.m. Question and Answer Session